EpiPen Makers, Pfizer Inc. and Mylan Specialty, Fined $625K Over "Deceptive" TV Ad

Published: Nov 08, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer and Mylan Specialty, makers of the EpiPen emergency allergic reaction drug injector, pay the state of Massachusetts $625,000 after the FDA says their week-long television ad misled consumers. EpiPen providers Pfizer (NYSE:PFE) and Mylan Specialty agreed to a $625,000 settlement to close the books on charges that they misled consumers about the efficacy of the emergency allergy medication dispenser. The companies in April aired a television commercial, and ran a parallel print ad, that showed a mother and her son discussing the EpiPen system on the way to a birthday party.

Help employers find you! Check out all the jobs and post your resume.

Back to news